These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22490592)

  • 1. Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats.
    Dai HY; Zheng M; Tang RN; Ma KL; Ni J; Liu BC
    Chin Med J (Engl); 2012 Mar; 125(5):888-93. PubMed ID: 22490592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
    Ma RX; Xu Y; Zhang J; Li YS; Liu LQ
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):117-22. PubMed ID: 22490812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade.
    Bonnet F; Candido R; Carey RM; Casley D; Russo LM; Osicka TM; Cooper ME; Cao Z
    J Hypertens; 2002 Aug; 20(8):1615-24. PubMed ID: 12172324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
    Bonnet F; Cooper ME; Kawachi H; Allen TJ; Boner G; Cao Z
    Diabetologia; 2001 Jul; 44(7):874-7. PubMed ID: 11508272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy.
    Tunçdemir M; Oztürk M
    Acta Histochem; 2011 Dec; 113(8):826-32. PubMed ID: 21269661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of xenogeneic transplantation of umbilical cord-derived mesenchymal stem cells combined with irbesartan on renal podocyte damage in diabetic rats.
    Meng J; Gao X; Liu X; Zheng W; Wang Y; Wang Y; Sun Z; Yin X; Zhou X
    Stem Cell Res Ther; 2024 Jul; 15(1):239. PubMed ID: 39080783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.
    Hartner A; Cordasic N; Klanke B; Menendez-Castro C; Veelken R; Schmieder RE; Hilgers KF
    Biochim Biophys Acta; 2014 Apr; 1842(4):558-65. PubMed ID: 24418215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction.
    Liu BC; Xia HL; Wu JN; Zhang XL; Liu DG; Gong YX
    Acta Pharmacol Sin; 2007 Nov; 28(11):1810-8. PubMed ID: 17959033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E; Kim J; Ho Kim S; Kim S; Cho MH
    Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells.
    Niu H; Nie L; Liu M; Chi Y; Zhang T; Li Y
    BMC Nephrol; 2014 Aug; 15():135. PubMed ID: 25142208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.